Annual CFO:
-$171.17M-$96.41M(-128.96%)Summary
- As of today, APGE annual cash from operations is -$171.17 million, with the most recent change of -$96.41 million (-128.96%) on December 31, 2024.
- During the last 3 years, APGE annual cash from operations has fallen by -$154.75 million (-942.03%).
- APGE annual cash from operations is now -942.03% below its all-time high of -$16.43 million, reached on December 31, 2022.
Performance
APGE Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$54.26M+$7.77M(+12.53%)Summary
- As of today, APGE quarterly cash from operations is -$54.26 million, with the most recent change of +$7.77 million (+12.53%) on September 30, 2025.
- Over the past year, APGE quarterly cash from operations has dropped by -$11.73 million (-27.59%).
Performance
APGE Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$232.47M-$11.73M(-5.31%)Summary
- As of today, APGE TTM cash from operations is -$232.47 million, with the most recent change of -$11.73 million (-5.31%) on September 30, 2025.
- Over the past year, APGE TTM cash from operations has dropped by -$99.26 million (-74.51%).
Performance
APGE TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
APGE Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -129.0% | -27.6% | -74.5% |
| 3Y3 Years | -942.0% | -649.6% | -3111.9% |
| 5Y5 Years | -942.0% | -100.0% | -100.0% |
APGE Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -942.0% | at low | -649.6% | +19.9% | -3111.9% | at low |
| 5Y | 5-Year | -942.0% | at low | >-9999.0% | +19.9% | >-9999.0% | at low |
| All-Time | All-Time | -942.0% | at low | >-9999.0% | +19.9% | >-9999.0% | at low |
APGE Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$54.26M(+12.5%) | -$232.47M(-5.3%) |
| Jun 2025 | - | -$62.03M(-28.0%) | -$220.74M(-17.4%) |
| Mar 2025 | - | -$48.48M(+28.4%) | -$188.01M(-9.8%) |
| Dec 2024 | -$171.17M(-129.0%) | -$67.71M(-59.2%) | -$171.17M(-28.5%) |
| Sep 2024 | - | -$42.52M(-45.1%) | -$133.21M(-20.5%) |
| Jun 2024 | - | -$29.30M(+7.4%) | -$110.57M(-15.4%) |
| Mar 2024 | - | -$31.64M(-6.3%) | -$95.84M(-28.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$74.76M(-355.1%) | -$29.75M(-49.7%) | -$74.76M(-66.1%) |
| Sep 2023 | - | -$19.88M(-36.4%) | -$45.01M(-39.1%) |
| Jun 2023 | - | -$14.57M(-38.0%) | -$32.37M(-81.9%) |
| Mar 2023 | - | -$10.56M(-45.9%) | -$17.80M(-145.9%) |
| Dec 2022 | -$16.43M | - | - |
| Sep 2022 | - | -$7.24M(>-9900.0%) | -$7.24M(>-9900.0%) |
| Jun 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2022 | - | $0.00 | $0.00 |
FAQ
- What is Apogee Therapeutics, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Apogee Therapeutics, Inc.?
- What is Apogee Therapeutics, Inc. annual cash from operations year-on-year change?
- What is Apogee Therapeutics, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Apogee Therapeutics, Inc.?
- What is Apogee Therapeutics, Inc. quarterly cash from operations year-on-year change?
- What is Apogee Therapeutics, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Apogee Therapeutics, Inc.?
- What is Apogee Therapeutics, Inc. TTM cash from operations year-on-year change?
What is Apogee Therapeutics, Inc. annual cash from operations?
The current annual cash from operations of APGE is -$171.17M
What is the all-time high annual cash from operations for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high annual cash from operations is -$16.43M
What is Apogee Therapeutics, Inc. annual cash from operations year-on-year change?
Over the past year, APGE annual cash from operations has changed by -$96.41M (-128.96%)
What is Apogee Therapeutics, Inc. quarterly cash from operations?
The current quarterly cash from operations of APGE is -$54.26M
What is the all-time high quarterly cash from operations for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high quarterly cash from operations is $0.00
What is Apogee Therapeutics, Inc. quarterly cash from operations year-on-year change?
Over the past year, APGE quarterly cash from operations has changed by -$11.73M (-27.59%)
What is Apogee Therapeutics, Inc. TTM cash from operations?
The current TTM cash from operations of APGE is -$232.47M
What is the all-time high TTM cash from operations for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high TTM cash from operations is $0.00
What is Apogee Therapeutics, Inc. TTM cash from operations year-on-year change?
Over the past year, APGE TTM cash from operations has changed by -$99.26M (-74.51%)